Therapeutic Goods (Medical Devices—Excluded Purposes) Amendment (COVID‑19 Self‑Testing) Specification 2022
Dated 25 October 2022
Adjunct Professor John Skerritt
Deputy Secretary
Health Products Regulation Group
Department of Health and Aged Care
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020
This instrument is the Therapeutic Goods (Medical Devices—Excluded Purposes) Amendment (COVID‑19 Self‑Testing) Specification 2022.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | The day after this instrument is registered. |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under section 41BEA of the Therapeutic Goods Act 1989.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
Therapeutic Goods (Medical Devices—Excluded Purposes) Specification 2020
1 Part 1A of Schedule 1 (table item 1, column 2, paragraph (c))
Repeal the paragraph, substitute:
(c) test for the presence of SARS-CoV-2 antigens or SARS-CoV-2 nucleic acid
2 Part 2 of Schedule 1 (table item 1, column 2, paragraph (c))
Repeal the paragraph, substitute:
(c) test for the presence of SARS-CoV-2 antigens or SARS-CoV-2 nucleic acid